Skip to main content
. 2012 May;14(5):333–340. doi: 10.1111/j.1477-2574.2012.00454.x

Figure 1.

Figure 1

Odds ratio (OR) for developing steatosis when chemotherapy is administered in the presence or absence of diabetes, elevated body mass index (BMI) or metabolic syndrome. The effect of chemotherapy can be seen to be independent of the co-morbidity. For all patients, the OR for steatosis when administered chemotherapy is displayed as the diamond at the bottom of the diagram